University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd — New Lenox, Illinois

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd is a clinical research site located in New Lenox, Illinois, United States 60451.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd?

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd conducted?

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd has 1 clinical trials on record. Their work covers Breast Cancer.

Is University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd accredited by Crixeo Health?

University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.